SENTARA NORFOLK GENERAL HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $8.5M
- Transactions
- 1,609
- Companies
- 40
- Average per transaction
- $5,261
Who reported the payments
| Abbott | $1,784,949 |
| Edwards Lifesciences | $1,446,628 |
| Boston Scientific | $1,151,146 |
| Eli Lilly | $440,025 |
| Endotronix, Inc. | $362,920 |
| Shockwave Medical, Inc | $305,928 |
| Medtronic | $281,272 |
| United Therapeutics Corporation | $257,299 |
| Biosense Webster, Inc. | $186,708 |
| Merck | $171,580 |
| Atricure, Inc. | $111,453 |
| Roche Diagnostics Operations, Inc. | $110,542 |
| Medical Device Business Services, Inc. | $104,228 |
| AbbVie | $95,127 |
| Bard Peripheral Vascular, Inc. | $90,568 |
| Paragonix Technologies, Inc. | $89,571 |
| Adagio Medical, Inc. | $83,694 |
| Janssen Research & Development, LLC | $81,651 |
| Inari Medical, Inc. | $72,321 |
| Jenavalve Technology, Inc. | $71,338 |
| Philips North America LLC | $71,005 |
| AstraZeneca | $64,631 |
| Procyrion, Inc. | $62,425 |
| Boehringer Ingelheim | $54,712 |
| Bolton Medical Inc | $53,253 |
| Transmedics, Inc. | $46,171 |
| Astrazeneca UK Limited | $45,912 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $44,294 |
| Shape Memory Medical Inc. | $42,049 |
| UCB SA | $42,039 |
| Siemens Medical Solutions USA, Inc. | $36,891 |
| Cardiovascular Systems Inc. | $36,320 |
| American Regent | $35,593 |
| Sterilmed, Inc. | $33,507 |
| Angiodynamics, Inc. | $30,406 |
| Tyber Medical, LLC | $29,990 |
| Abiomed | $29,665 |
| Bristol Myers Squibb | $28,592 |
| Stryker | $26,231 |
| Hill-rom Company, Inc | $24,707 |